What is Chronic Limb-Threatening Ischemia (CLTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Chronic Limb-Threatening Ischemia (CLTI)

Chronic limb-threatening ischemia (CLTI) is a clinical syndrome defined by the presence of peripheral artery disease in combination with ischemic rest pain, non-healing lower limb ulceration of >2 weeks duration, or gangrene involving any portion of the foot or lower limb. 1

Key Characteristics of CLTI

  • CLTI represents the end-stage form of peripheral arterial disease (PAD) with threatened limb viability related to several factors, not just severe ischemia 1
  • The term CLTI is preferred over the former term "critical limb ischemia" for several important reasons:
    • "Critical" implies urgent treatment is needed to avoid limb loss, while some patients can maintain their limbs for extended periods even without revascularization 1
    • There is an increasing predominance of diabetes in these situations (present in 50-70% of cases), which often presents as neuro-ischemic diabetic foot ulcers 1
    • The risk of amputation depends not only on the severity of ischemia but also on the presence of wounds and infection 1

Diagnostic Criteria for CLTI

  • Ischemic rest pain, typically in the forefoot with objectively confirmed hemodynamic studies 1:
    • Ankle-brachial index (ABI) <0.40
    • Ankle pressure <50 mmHg
    • Toe pressure <30 mmHg
    • Transcutaneous oxygen pressure (TcPO2) <30 mmHg
  • Diabetic foot ulcer 1
  • Non-healing lower limb or foot ulceration ≥2 weeks duration 1
  • Gangrene involving any portion of the foot or lower limb 1

WIfI Classification System for CLTI

The WIfI (Wound, Ischemia, foot Infection) classification system is recommended for the initial assessment and risk stratification of all patients with CLTI 1, 2:

  • Wound (W): Graded from 0 (none) to 3 (severe) based on ulcer depth and extent of tissue loss 1
  • Ischemia (I): Graded from 0 (none) to 3 (severe) based on hemodynamic parameters 1
  • foot Infection (fI): Graded from 0 (none) to 3 (severe) based on clinical signs of infection 1

Each factor is independently associated with the risk of amputation and helps guide treatment decisions 1, 2

Clinical Presentation

  • Ischemic rest pain is typically described as a burning pain in the arch or distal foot that occurs while the patient is recumbent but is relieved when the feet are in a dependent position 3
  • CLTI is associated with high risk of limb loss and mortality, similar to a terminal cancer disease, with significant impact on quality of life and healthcare costs 4
  • Lower limb amputation associated with CLTI has 30-day mortality rates of up to 22% 1
  • CLTI should be distinguished from acute limb ischemia (ALI), which has a duration of less than 2 weeks and is characterized by the "6 P's": pain, pallor, pulselessness, poikilothermia, paresthesias, and paralysis 1, 5

Management Considerations

  • All patients with suspected CLTI should be urgently referred to a vascular specialist 2
  • Management should be by a vascular team including at least a vascular physician, vascular surgeon, and radiologist 1
  • Revascularization should be attempted to rapidly restore inline direct blood flow to the foot 1
  • Best medical therapy should be provided to all patients with CLTI, including antithrombotic, lipid-lowering, antihypertensive, and glycemic control agents 2
  • In patients with diabetes, glycemic control is particularly important for improved limb-related outcomes 1

CLTI represents a significant clinical challenge requiring prompt diagnosis and multidisciplinary management to prevent limb loss and reduce mortality 4, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Peripheral Artery Disease Clinical Signs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.